HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

6th Edition of

International Public Health Conference

March 15-17, 2027 | Singapore

Clinical Trials

Clinical Trials

Clinical trials are prospective biomedical or behavioural research studies involving human subjects that aim to provide answers to particular questions about biomedical or behavioural interventions. These include both established and novel treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) as well as interventions that have already been tried and tested but still require more research and comparison. Data on dosage, safety, and effectiveness are produced by clinical trials. In the nation where therapy approval is sought, they are only carried out after receiving approval from the health authority or ethics committee. These authorities are in charge of evaluating the trial's risk/benefit ratio; their approval merely permits the trial to proceed and does not imply that the therapy is "safe" or effective. In small pilot studies, researchers first enrol volunteers or patients, depending on the product type and stage of development.

Committee Members
Speaker at IPHC 2027 - Kenneth R Pelletier

Kenneth R Pelletier

University of California, United States
Speaker at IPHC 2027 - Thomas J Webster

Thomas J Webster

School of Health Sciences and Biomedical Engineering, Hebei University of Technology, Tianjin, China
Speaker at IPHC 2027 - Bernd Blobel

Bernd Blobel

University of Regensburg, Germany
IPHC 2027 Speakers
Speaker at IPHC 2027 - Bernd Blobel

Bernd Blobel

University of Regensburg
Speaker at IPHC 2027 - Iuliana Vintila

Iuliana Vintila

Dunarea de Jos University, Galati
Speaker at IPHC 2027 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences
Speaker at IPHC 2027 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

University Science Malaysia

Submit your abstract Today

YouTube
WhatsAppWhatsApp